.png)
The final Organoid and Organ-on-a-chip research presentations are now detailed in the agenda. Key areas include Oncology, Regenerative Medicine, Gut and Microbiome, Organoid Intelligence, Pre and post-natal organoid and chip applications in Paediatrics and showcases with GSK and AstraZeneca on Commercial Drug Discovery. There are also Academic Showcases from Universities of Oxford, KU Leuven, Oslo and QMUL. The closing presentation focusses on the importance of organ connection for comprehensive understanding of mechanism in disease.
